BOK Financial’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
BOK Financial's MRNA Position: Q3 2026 in Review
BOK Financial reduced its Moderna (MRNA) stake by 92% in Q3 2026, selling an estimated $72.7K and leaving 61 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #922.
BOK Financial first reported a position in MRNA in Q3 2019 and has held it in 24 quarters since. The position peaked at $6.03M in Q1 2022. 967 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.
- BOK Financial held 61 shares of Moderna worth $11.7K as of Q3 2026.
- BOK Financial sold 675 Moderna shares in Q3 2026, an estimated $72.7K.
- Moderna made up ﹤0.01% of BOK Financial's portfolio in Q3 2026, its #922 holding.
- BOK Financial first reported a position in Moderna in Q3 2019 and has held it in 24 quarters since.
- BOK Financial's Moderna position peaked at $6.03M in Q1 2022.
- 967 funds tracked by Wall St. Rank held Moderna as of Q3 2026.
Based on BOK Financial's 13F filing for Q3 2026, filed 27 Oct 2026.